Feldmann Marc Insider Trades

Insider Trading History

Track insider trading activity for Feldmann Marc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ethzilla
Ethzilla ETHZ
Director
Holding Value $886k 250,874 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.53
180 Life Sciences - Warrants (07/11/2025)
180 Life Sciences - Warrants (07/11/2025) ATNFW
Director
Holding Value $108k 250,874 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$677 135,377 shares
$0.01
$0.43
180 Life Sciences
180 Life Sciences ATNF
Director
Holding Value $1.77M 250,874 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.6k 135,377 shares
$0.21
$7.04
180 Life Sciences - Warrants (07/11/2025)
180 Life Sciences - Warrants (07/11/2025) ATNFW
Director
Holding Value $49.7k 115,497 shares
Last Trade
Dec 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$153 25,000 shares
$0.01
$0.43
Ethzilla
Ethzilla ETHZ
Director
Holding Value $408k 115,497 shares
Last Trade
Dec 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$3.53
180 Life Sciences
180 Life Sciences ATNF
Director
Holding Value $813k 115,497 shares
Last Trade
Dec 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.75k 25,000 shares
$0.19
$7.04
Ethzilla
Ethzilla ETHZ
Director
Holding Value $53k 15,000 shares
Last Trade
Sep 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.53
180 Life Sciences - Warrants (07/11/2025)
180 Life Sciences - Warrants (07/11/2025) ATNFW
Director
Holding Value $6.45k 15,000 shares
Last Trade
Sep 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150 15,000 shares
$0.01
$0.43
180 Life Sciences
180 Life Sciences ATNF
Director
Holding Value $106k 15,000 shares
Last Trade
Sep 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.1k 15,000 shares
$0.67
$7.04
Ethzilla
Ethzilla ETHZ
Director
Holding Value $9.92M 2,809,930 shares
Last Trade
Dec 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$3.53
180 Life Sciences
180 Life Sciences ATNF
Director
Holding Value $19.8M 2,809,930 shares
Last Trade
Dec 09, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4M 50,000 shares
$80.00
$7.04
180 Life Sciences
180 Life Sciences ATNF
Director
Holding Value $19.4M 2,759,930 shares
Last Trade
Dec 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.41M 30,536 shares
$79.00
$7.04
Ethzilla
Ethzilla ETHZ
Director
Holding Value $9.74M 2,759,930 shares
Last Trade
Dec 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.53
Ethzilla
Ethzilla ETHZ
Director
Holding Value $9.72M 2,754,394 shares
Last Trade
Sep 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.53
Ethzilla
Ethzilla ETHZ
Director
Holding Value $9.24M 2,617,758 shares
Last Trade
Apr 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.53

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up